GA2LEN ANACARE consensus statement: Potential of omalizumab in food allergy management.
Saved in:
| Title: | GA2LEN ANACARE consensus statement: Potential of omalizumab in food allergy management. |
|---|---|
| Authors: | Zuberbier, Torsten1,2 (AUTHOR) torsten.zuberbier@charite.de, Muraro, Antonella3 (AUTHOR), Nurmatov, Ulugbek4 (AUTHOR), Arasi, Stefania5 (AUTHOR), Stevanovic, Katarina1,2 (AUTHOR), Anagnostou, Aikaterini6 (AUTHOR), Bonaguro, Roberta3 (AUTHOR), Chinthrajah, Sharon7 (AUTHOR), Lack, Gideon8,9,10 (AUTHOR), Fiocchi, Alessandro5 (AUTHOR), Le, Thuy‐My11,12 (AUTHOR), Turner, Paul13 (AUTHOR), Lozano, Montserrat Alvaro14,15,16 (AUTHOR), Angier, Elizabeth17 (AUTHOR), Barni, Simona18 (AUTHOR), Bégin, Phillippe19,20 (AUTHOR), Ballmer‐Weber, Barbara21,22 (AUTHOR), Cardona, Victoria23 (AUTHOR), Bindslev‐Jensen, Carsten24 (AUTHOR), Cianferoni, Antonella25 (AUTHOR) |
| Source: | Clinical & Translational Allergy. Nov2024, Vol. 14 Issue 11, p1-11. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
